Low free thyroxine levels and isolated hypothyroxinemia, but not subclinical hypothyroidism, are associated with an increased risk for gestational diabetes.
Youth-onset metabolic diseases are a major global health challenge. This review looks at variations in incidence, management and burden, epidemiology and outcomes, and the need for early prevention strategies.
Type 2 diabetes remission is increasingly recognized as an achievable goal, but what's known about the optimal therapeutic options, how remission impacts clinical outcomes, and predictors of sustained long-term remission?
In a large database analysis, use of GLP-1 receptor agonists was associated with a reduced symptom burden in people with fibromyalgia, but further studies with validated outcome measures are needed.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
Vigilance is key in people with type 1 diabetes who take tirzepatide. In this patient, ketoacidosis developed after malaise, aphagia, and malnutrition decreased his insulin requirements and he couldn’t manage his pump and sensor.
Metabolic disorders, like hyperlipidemia and diabetes, are high-risk factors for developing retinal artery occlusion. Timely intra-arterial thrombolysis in this case was crucial for preserving the patient's vision.
A 51-year-old man presented with severe generalized pain. Raised HbA1c and blood glucose levels, plus findings of pre-proliferative diabetic retinopathy, led to a diagnosis of type 2 diabetes and diabetic polyneuropathy.
In 2005 the US FDA approved the first GLP-1 medicine for type 2 diabetes, marking the start of a remarkable journey that goes beyond the stimulation of insulin secretion.
Prof. Daniel Drucker gives us a fascinating insight into the early work on GLP-1 and discusses how these medicines are impacting the lives of people with diabetes and obesity. He covers what's known about how they work, treatment duration, side effects, and the role of bariatric surgery, plus what's in the pipeline in terms of drug development and the indications that GLP-1 medicines may be used to treat in the future.
Gonadotropin-releasing hormone (GnRH) therapy, a cornerstone in the treatment of various oncological and reproductive conditions, has been increasingly associated with significant cardiovascular risks, particularly when administered long-term.
Diabetic cardiomyopathy (DCM), defined as cardiac impairment resulting from the development of diabetes mellitus, has emerged as a global epidemic. DCM primarily denotes myocardial metabolic impairment induced by elevated glucose levels, with …
Obesity is a global health concern linked to metabolic and cardiovascular complications. Bariatric surgery is an effective treatment, with sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) being the most studied procedures. This …
Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.
Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
Treating children with hormone disorders is complex and requires tailored management. To help you provide the most effective care, we deliver resources covering adrenal, thyroid, pituitary, growth, and puberty disorders, obesity, and diabetes.
Original Article―Liver, Pancreas, and Biliary Tract
With the advent of direct-acting antivirals (DAAs), sustained virologic response (SVR) has become nearly universal for patients with chronic hepatitis C virus (HCV) infection [ 1 ]. The eradication of HCV not only significantly reduces the burden …
Gestational diabetes mellitus (GDM) is a prevalent pregnancy-related disorder affecting 10–30% of pregnancies worldwide, and accounts for nearly 90% of diabetes cases in pregnancy [ 1 – 3 ]. It is defined as a glucose metabolism disorder detected …
India currently has 101 million people with diabetes, and 136 million people with prediabetes [ 1 ]. Indians develop type 2 diabetes (T2D) at younger ages and have lower levels of obesity than Western populations [ 2 – 4 ]. The incidence of new …
Artificial intelligence (AI) is transforming ophthalmology and holds great promise for improving patient care. AI algorithms have been brought to the forefront, enabling advancements in screening, diagnostics, and monitoring of ocular diseases …
Low free thyroxine levels and isolated hypothyroxinemia, but not subclinical hypothyroidism, are associated with an increased risk for gestational diabetes.
Type 2 diabetes remission is increasingly recognized as an achievable goal, but what's known about the optimal therapeutic options, how remission impacts clinical outcomes, and predictors of sustained long-term remission?
Youth-onset metabolic diseases are a major global health challenge. This review looks at variations in incidence, management and burden, epidemiology and outcomes, and the need for early prevention strategies.
Vigilance is key in people with type 1 diabetes who take tirzepatide. In this patient, ketoacidosis developed after malaise, aphagia, and malnutrition decreased his insulin requirements and he couldn’t manage his pump and sensor.
